Eloxx Pharmaceuticals
@eloxx_pharma
Clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates to treat rare and ultra-rare premature stop codon diseases.
ID: 1281355319185215488
https://www.eloxxpharma.com/ 09-07-2020 22:31:38
74 Tweet
176 Takipçi
32 Takip Edilen
In conjunction with #RareDiseaseDay, we announce initiation of Phase 2 clinical study of ELX-02 for the treatment of #AlportSyndrome with the first patients being dosed. Read the press release and learn about our unique ribosome-modulating technology. investors.eloxxpharma.com/news-releases/…
